Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zurletrectinib by InnoCare Pharma for Central Nervous System (CNS) Tumor: Likelihood of Approval
Zurletrectinib is under clinical development by InnoCare Pharma and currently in Phase I for Central Nervous System (CNS) Tumor. According...